Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3992
Source ID: NCT03748810
Associated Drug: Empagliflozin
Title: Head-to-head Comparison of Empagliflozin and Dapagliflozin
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type2 Diabetes
Interventions: DRUG: Empagliflozin|DRUG: Dapagliflozin
Outcome Measures: Primary: Changes in HbA1c from baseline to week 156 (3-year), Changes in HbA1c from baseline to week 156 (3-year), Baseline, week 156 (3-year)|Changes in fasting plasma glucose from baseline to week 156 (3-year), Changes in fasting plasma glucose from baseline to week 156 (3-year), Baseline, week 156 (3-year) | Secondary: Changes in HbA1c from baseline to week 104 (2-year), Changes in HbA1c from baseline to week 104 (2-year), Baseline, week 104 (2-year)|Changes in HbA1c from baseline to week 52 (1-year), Changes in HbA1c from baseline to week 52 (1-year), Baseline, week 52 (1-year)|Changes in HbA1c from baseline to week 24, Changes in HbA1c from baseline to week 24, Baseline, Week 24|Changes in fasting plasma glucose from baseline to week 12, Changes in fasting plasma glucose from baseline to week 12, Baseline, Week 12|Changes in fasting plasma glucose from baseline to week 24, Changes in fasting plasma glucose from baseline to week 24, Baseline, Week 24|Changes in fasting plasma glucose from baseline to week 56 (1-year), Changes in fasting plasma glucose from baseline to week 56 (1-year), Baseline, Week 56 (1-year)|Changes in weight between baseline and week 156 (3-year), Changes in weight between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in weight between baseline and week 104 (2-year), Changes in weight between baseline and week 104 (2-year), Baseline, Week 104 (2-year)|Changes in weight between baseline and week 52, Changes in weight between baseline and week 52, Baseline, Week 52|Changes in weight between baseline and week 24, Changes in weight between baseline and week 24, Baseline, Week 24|Changes in weight between baseline and week 12, Changes in weight between baseline and week 12, Baseline, Week 12|Changes in systolic blood pressure between baseline and week 156 (3-year), Changes in systolic blood pressure between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in systolic blood pressure between baseline and week 104 (2-year), Changes in systolic blood pressure between baseline and week 104 (2-year), Baseline, Week 104 (2-year)|Changes in systolic blood pressure between baseline and week 52, Changes in systolic blood pressure between baseline and week 52, Baseline, Week 52|Changes in systolic blood pressure between baseline and week 24, Changes in systolic blood pressure between baseline and week 24, Baseline, Week 24|Changes in systolic blood pressure between baseline and week 12, Changes in systolic blood pressure between baseline and week 12, Baseline, Week 12|Changes in diastolic blood pressure between baseline and week 156 (3-year), Changes in diastolic blood pressure between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in diastolic blood pressure between baseline and week 104 (2-year), Changes in diastolic blood pressure between baseline and week 104 (2-year), Baseline, Week 104 (2-year)|Changes in diastolic blood pressure between baseline and week 52, Changes in diastolic blood pressure between baseline and week 52, Baseline, Week 52|Changes in diastolic blood pressure between baseline and week 24, Changes in diastolic blood pressure between baseline and week 24, Baseline, Week 24|Changes in diastolic blood pressure between baseline and week 12, Changes in diastolic blood pressure between baseline and week 12, Baseline, Week 12|Changes in total cholesterol between baseline and week 156 (3-year), Changes in total cholesterol between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in triglyceride between baseline and week 156 (3-year), Changes in triglyceride between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in LDL-cholesterol between baseline and week 156 (3-year), Changes in LDL-cholesterol between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Changes in HDL-cholesterol between baseline and week 156 (3-year), Changes in HDL-cholesterol between baseline and week 156 (3-year), Baseline, Week 156 (3-year)|Percentage of patients with hypoglycemic episodes between baseline and week 156 (3-year), All episodes consistent with hypoglycemic episodes with or without a confirmatory blood glucose reading were collected, Baseline, Week 156 (3-year)|Percentage of patients with at least 1 episode of genitourinary tract infections between baseline and week 156 (3-year), Percentage of patients with at least 1 episode of genitourinary tract infections, Baseline, Week 156 (3-year)
Sponsor/Collaborators: Sponsor: Chungbuk National University Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 600
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2016-01-01
Completion Date: 2022-06-30
Results First Posted:
Last Update Posted: 2022-07-20
Locations: Chungbuk National University Hospital, Cheonju, Chungcheongbuk-do, 28644, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT03748810